BAA contract titled, "computational drug delivery: leveraging predictive models to develop bioequivalent generic long-acting injections."
Ended Definitive Contract Awarded Last action
- Contract number
- HHSF223201510102C
- Awardee
-
Qrono, Inc. UEI S8NSYCMSNF79
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $694,585
Award facts
- Opportunity
-
- FDABAA1500121 Solicitation number
- Food and Drug Administration Broad Agency Announcement for the Advanced Research and Development of Regulatory Science Award Notice · Posted Feb 23, 2015
- Contract value 100% obligated
- $694,584.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Pittsburgh, PA 15213, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$9,627 | |
| Change Order | $91,906 | |
| Exercise an Option | $321,366 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $290,940 |
About this award
This federal contract award was made by the Food and Drug Administration (FDA), a civilian agency, to Qrono, Inc., a for-profit company specializing in medical and scientific research and development. The $694,584.58 cost-plus-fixed-fee contract, titled "Computational Drug Delivery: Leveraging Predictive Models to Develop Bioequivalent Generic Long-Acting Injections," is focused on developing innovative drug delivery systems and immunotherapy approaches. The contract has an ultimate completion date of October 31, 2019 and was awarded on August 28, 2015. This contract does not have a set-aside designation. Qrono, Inc. has also received multiple federal research grants from agencies like the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to support the development of novel oral nanomedicine technologies and immunotherapies.
Quick answers
Who was awarded contract HHSF223201510102C?
HHSF223201510102C was awarded to Qrono, Inc. by Food and Drug Administration (Department of Health and Human Services) on August 28, 2015.
How much is contract HHSF223201510102C worth?
The government has obligated $694,585 on HHSF223201510102C.
Was contract HHSF223201510102C competed?
The extent of competition for HHSF223201510102C was full and open competition. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award